The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Obesity and Cardiovascular Disease
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.068 · Cited by 2,326
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Farnesoid X receptor is essential for normal glucose homeostasis
Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 882
Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Self-citationDifferential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Maloney, P. R., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 527
Denson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Keitel, V., Donner, M., Winandy, S., Kubitz, R., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.171 · Cited by 418
The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis
Lambert, G., Amar, M. J. A., Guo, G., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 392
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 368
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Kerr, T. A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D. W., & Schwarz, M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00154-5 · Cited by 351
FXR, a multipurpose nuclear receptor
Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A., & Zhang, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.002 · Cited by 344
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., Mioskowski, C., Auwerx, J., & Saladin, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.130 · Cited by 340
Kast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Ballatori, N., Christian, W. V., Lee, J. Y., Dawson, P. A., Soroka, C. J., Boyer, J. L., Madejczyk, M. S., & Li, N. (2005) · Hepatology · doi:10.1002/hep.20961 · Cited by 335
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Görg, B., Selbach, O., Häussinger, D., & Kubitz, R. (2007) · Hepatology · doi:10.1002/hep.21458 · Cited by 310
Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR
Mi, L.-Z., Devarakonda, S., Harp, J. M., Han, Q., Pellicciari, R., Willson, T. M., Khorasanizadeh, S., & Rastinejad, F. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00112-6 · Cited by 307
Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., & Auwerx, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015864 · Cited by 298
Zhang, S., Wang, J., Liu, Q., & Harnish, D. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.025 · Cited by 290
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Stayrook, K. R., Bramlett, K. S., Savkur, R. S., Ficorilli, J., Cook, T., Christe, M. E., Michael, L. F., & Burris, T. P. (2005) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288
Claudel, T., Sturm, E., Duez, H., Torra, I. P., Sirvent, A., Kosykh, V., Fruchart, J.-C., Dallongeville, J., Hum, D. W., Kuipers, F., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14505 · Cited by 286
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S. J., Zeng, M., Yang, S., Hoos, L., Tetzloff, G., Levitan, D., Murgolo, N. J., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060537 · Cited by 277
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Duran-Sandoval, D., Mautino, G., Martin, G., Percevault, F., Barbier, O., Fruchart, J.-C., Kuipers, F., & Staels, B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.890 · Cited by 257
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 246
Guggulipid for the Treatment of Hypercholesterolemia: A Randomized Controlled Trial
Szapary, P. O., Wolfe, M. L., Bloedon, L. T., Cucchiara, A. J., DerMarderosian, A. H., Cirigliano, M. D., & Rader, D. J. (2003) · JAMA · doi:10.1001/jama.290.6.765 · Cited by 246
Duran-Sandoval, D., Cariou, B., Percevault, F., Hennuyer, N., Grefhorst, A., van Dijk, T. H., Gonzalez, F. J., Fruchart, J.-C., Kuipers, F., & Staels, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501931200 · Cited by 239
Moore, D. D., Kato, S., Xie, W., Mangelsdorf, D. J., Schmidt, D. R., Xiao, R., & Kliewer, S. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.6 · Cited by 209
Brendel, C., Schoonjans, K., Botrugno, O. A., Treuter, E., & Auwerx, J. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0194 · Cited by 201
Antiatherosclerotic effect of farnesoid X receptor
Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01075.2008 · Cited by 199
Self-citationTargeting farnesoid X receptor for liver and metabolic disorders
Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196
Self-citationFiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 196
Self-citationT0901317 is a dual LXR/FXR agonist
Houck, K. A., Borchert, K. M., Hepler, C. D., Thomas, J. S., Bramlett, K. S., Michael, L. F., & Burris, T. P. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.007 · Cited by 186
Hanniman, E. A., Lambert, G., McCarthy, T. C., & Sinal, C. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500390-jlr200 · Cited by 179
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
Otte, K., Kranz, H., Kober, I., Thompson, P., Hoefer, M., Haubold, B., Remmel, B., Voss, H., Kaiser, C., Albers, M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.864-872.2003 · Cited by 176
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/−Mice
Zhang, Y., Wang, X., Vales, C., Lee, F. Y., Lee, H., Lusis, A. J., & Edwards, P. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235697.35431.05 · Cited by 169
Bile acids and signal transduction: Role in glucose homeostasis
Nguyen, A., & Bouscarel, B. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.014 · Cited by 165
Hartman, H. B., Gardell, S. J., Petucci, C. J., Wang, S., Krueger, J. A., & Evans, M. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800619-jlr200 · Cited by 157
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J. H., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 155
Akwabi-Ameyaw, A., Bass, J. Y., Caldwell, R. D., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Jones, S. A., Kaldor, I. W., Liu, Y., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.073 · Cited by 151
The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand
Burris, T. P., Montrose, C., Houck, K. A., Osborne, H. E., Bocchinfuso, W. P., Yaden, B. C., Cheng, C., Zink, R. W., Barr, R. J., Hepler, C. D., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007054 · Cited by 135
Farnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 129
Self-citationTiwari, A., & Maiti, P. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.005 · Cited by 122
FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action
Shin, D.-J., & Osborne, T. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808747200 · Cited by 113
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
Jung, D., Inagaki, T., Gerard, R. D., Dawson, P. A., Kliewer, S. A., Mangelsdorf, D. J., & Moschetta, A. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700351-jlr200 · Cited by 107
Yu, C., Wang, F., Jin, C., Huang, X., & McKeehan, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411771200 · Cited by 106
Identification of Gene-selective Modulators of the Bile Acid Receptor FXR
Dussault, I., Beard, R., Lin, M., Hollister, K., Chen, J., Xiao, J. H., Chandraratna, R., & FORMAN, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209863200 · Cited by 106
Pellicciari, R., Sato, H., Gioiello, A., Costantino, G., Macchiarulo, A., Sadeghpour, B. M., Giorgi, G., Schoonjans, K., & Auwerx, J. H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070633p · Cited by 105
Feed-forward Regulation of Bile Acid Detoxification by CYP3A4
Stedman, C., Robertson, G. R., Coulter, S., & Liddle, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310258200 · Cited by 94
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation
Soisson, S. M., Parthasarathy, G., Adams, A. D., Sahoo, S. P., Sitlani, A., Sparrow, C. P., Cui, J., & Becker, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710981105 · Cited by 92
Evans, M. J., Mahaney, P. E., Borges-Marcucci, L., Lai, K., Wang, S., Krueger, J. A., Gardell, S. J., Huard, C., Martinez, R., Vlasuk, G. P., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90585.2008 · Cited by 92
Tan, K. P., Yang, M., & Ito, S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039370 · Cited by 91
Yang, J. I., Yoon, J., Myung, S. J., Gwak, G., Kim, W. K., Chung, G. E., Lee, S. H., Lee, S., Kim, C. Y., & Lee, H.-S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.001 · Cited by 74
Marzolini, C., Tirona, R. G., Gervasini, G., Balasubramanian, P., Assem, M., Lee, W., Leake, B. F., Schuetz, J. D., Schuetz, E. G., & Kim, R. B. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0025 · Cited by 73
Yu, X., Xue, C. C., Wang, G., & Zhou, S. (2007) · Current Drug Metabolism · doi:10.2174/138920007782798171 · Cited by 58
Farnesoid X receptor agonists in biliary tract disease
Fiorucci, S., & Baldelli, F. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328324f87e · Cited by 56
Self-citationSuzuki, T., Tamehiro, N., Sato, Y., Kobayashi, T., Ishii‐Watabe, A., Shinozaki, Y., Nishimaki‐Mogami, T., Hashimoto, T., Asakawa, Y., Inoue, K., et al. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08006fp · Cited by 36
Macchiarulo, A., Gioiello, A., Thomas, C., Massarotti, A., Nuti, R., Rosatelli, E., Sabbatini, P., Schoonjans, K., Auwerx, J. H., & Pellicciari, R. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800196h · Cited by 28
3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonists
Zhang, T., Zhou, J., Shi, L., Zhu, R., & Chen, M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.079 · Cited by 8
Cited by
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Commensal bacteria at the interface of host metabolism and the immune system
Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Korpela, K., Salonen, A., Virta, L. J., Kekkonen, R. A., Forslund, K., Bork, P., & de Vos, W. M. (2016) · Nature Communications · doi:10.1038/ncomms10410 · Cited by 698
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Microbial regulation of organismal energy homeostasis
Cani, P. D., Van Hul, M., Lefort, C., Depommier, C., Rastelli, M., & Everard, A. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0017-4 · Cited by 569
Metadata
- Authors
- Fiorucci, S., Mencarelli, A., Palladino, G., & Cipriani, S.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 30
- Issue
- 11
- Pages
- 570-580
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2093009918
- Cited by
- 346
- References
- 84
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.